This is the future of the AI-powered clinical laboratory, driven by an integrated platform of the EarlySign AlgoAnalyzer, AlgoMarkers, and custom machine learning algorithms built to take the clinical lab to a new level of post-analytical insights. EarlySign serves as a willing partner with the emerging generation of clinical laboratories who are committed to enhancing the healthcare landscape where labs are an integral part of outcome-based thinking as well as value based care.
The next generation of labs will embrace an evolving healthcare landscape that will optimize new and existing laboratory data to help inform actionable insights and be a true partner on the journey to value. With medical labs driving nearly 70% of clinical decisions, EarlySign’s AlgoAnalyzer platform can provide as an essential new modality for the future of every clinical digital laboratory. The AlgoAnalyzer platform was designed to integrate into the lab workflow as if it were a standard analyzer, it brings the power of ML and AI to the lab with smarter post-analytical insights.
The machine learning powered clinical laboratory is a key enabler of the value transformation of laboratory medicine which can be achieved through focusing on the post-analytical phase of the total testing process
Using EarlySign machine learning-based algorithms for the processing of panels of laboratory tests, their history and complementary clinical data can be optimized for insights to improve clinical decisions